Document:

Exhibit
4.4

 

WARRANT
AGREEMENT

 

This
Warrant Agreement (“Warrant Agreement”) is made as of [*], 2020, by and between Globis Acquisition Corp., a
Delaware company (the “Company”), and VStock Transfer, LLC (the “Warrant Agent”).

 

WHEREAS,
the Company is engaged in a public offering (the “Public Offering”) of 10,000,000 units (the “Units”)
of the Company (and up to 1,500,000 additional Units if the underwriters’ over-allotment option is exercised in full), each
Unit consisting of one share of common stock, par value $0.0001 (the “Common Stock”), and one warrant (the
“Public Warrant” or “Public Warrants”), each Public Warrant entitling its holder to purchase
one share of Common Stock (the “Public Warrant Shares”);

 

WHEREAS,
the Company has received a binding commitment from Globis SPAC LLC, a sponsor, and/or its designees pursuant to the Private Placement
Warrant Agreement, dated as of ______ __, 2020 (the “Globis Subscription Agreement”) to purchase an aggregate
of 3,555,556 warrants (or 3,688,889 warrants if the Over-Allotment Option (as defined below) is exercised in full) (together with
any warrants that Globis SPAC LLC or its affiliates may acquire upon conversion of working capital loans, the “Globis
Private Warrants”), and the Company has also received a binding commitment from Up and Up Capital, LLC, a sponsor (“Up
and Up Capital”), pursuant to the Private Placement Warrant Agreement, dated as of ______ __, 2020 (the “Up
and Up Warrant Subscription Agreement”) to purchase an aggregate of 500,000 warrants (the “Up and Up Private
Warrants”). In addition, the Company has also received a binding commitment from Up and Up Capital, pursuant to the
Unit Subscription Agreement, dated as of ________ __, 2020 (the “Up and Up Unit Subscription Agreement” and
together with the Up and Up Warrant Subscription Agreement and the Globis Subscription Agreement, the “Subscription Agreements”),
to purchase an aggregate of 95,833 units (or 100,833 units if the Over-Allotment Option is exercised in full) (the “Private
Placement Units”), consisting of one share of Common Stock and one warrant (the “Private Placement Unit Warrants”,
and together with the Up and Up Private Warrants and Globis Private Warrants, the “Private Warrants”, and together
with the Public Warrants, the “Warrants”), each Private Warrant entitling its holder to purchase one share
of Common Stock at an exercise price of $11.50 per share (“Private Warrant Shares”, and together with the Public
Warrant Shares, the “Warrant Shares”); and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form
S-1, No. 333-250939 (“Registration Statement”), for the registration, under the Securities Act of 1933, as
amended (the “Act”) of, among other securities, the Public Warrants; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection
with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and

 

WHEREAS,
the Company desires to provide for the form, terms and provisions of the Warrants, including the terms upon which they shall be
issued and exercised, and the respective rights, limitation of rights and immunities of the Company, the Warrant Agent and the
holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company
and countersigned by or on behalf of the Warrant Agent, as provided herein, the legally valid and binding obligations of the Company,
and to authorize the execution and delivery of this Warrant Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company
hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such
appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Warrant Agreement.

 

    	 

     

    

 

2.
Warrants.

 

2.1
Form of Warrant. Each Warrant shall be: issued in registered or book-entry form, as requested by the Company or the holder
of the Warrant. If the Warrant is issued in registered form, such Warrant shall be (a) in substantially the form of Exhibit A
hereto, the provisions of which are incorporated herein and (b) signed by, or bear the facsimile signature of, the Chairman of
the Board, the Chief Executive Officer or the Chief Financial Officer of the Company. In the event the person whose facsimile
signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant
before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of
issuance.

 

2.2
Effect of Countersignature. Unless and until countersigned by the Warrant Agent pursuant to this Warrant Agreement, a Warrant
shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3
Registration.

 

2.3.1
Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration
of the original issuance and transfers of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue
and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
instructions delivered to the Warrant Agent by the Company.

 

2.3.2
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name such Warrant shall be registered upon the Warrant Register (“Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise
thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4
Detachability of Public Warrants. Each of the securities comprising the Units will begin to trade separately on (i) the
fifty-second (52nd) day after the effectiveness of the Registration Statement, or (ii) such earlier date as Chardan Capital Markets
LLC, as representative of the underwriters (the “Representative”), shall determine is acceptable (such date,
the “Detachment Date”). In no event will separate trading of the securities comprising the Units commence until
the Company (i) files a Current Report on Form 8-K with the SEC including audited balance sheet reflecting our receipt of the
gross proceeds of the Public Offering, including the proceeds received by the Company from the exercise by the underwriters of
their right to purchase additional Units in the Public Offering (the “Over-Allotment Option”), if the Over-Allotment
Option is exercised prior to the filing of the Current Report on Form 8-K and (ii) issues a press release announcing when such
separate trading will begin.

 

2.5
Private Warrants. The Private Warrants (i) will be exercisable either for cash or on a cashless basis at the holder’s
option pursuant to Section 3.3; provided, however, that an effective registration statement registering the Warrant Shares is
not required for the exercise of the Private Warrants and the Private Warrants shall be exercisable on a cashless basis irrespective
of whether there is an effective registration statement registering the Warrant Shares, and (ii) will not be redeemable by the
Company. The provisions of this Section 2.5 may not be modified, amended or deleted without the prior written consent of the Representative.

 

3.
Terms and Exercise of Warrants.

 

3.1
Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject
to the provisions of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock
stated therein, at $11.50 per full share, subject to the adjustments provided in Section 4 hereof. The term “Warrant
Price” as used in this Warrant Agreement refers to the price per share at which a share of Common Stock may be purchased
at the time such Warrants are exercised. The Company will not issue fractional shares.

 

3.2
Duration of Warrants. A Warrant may be exercised only during the period (“Exercise
Period”) commencing on the later to occur of (i) the completion of the Company’s initial business combination
and (ii) 12 months following the closing of the Public Offering, and terminating at 5:00 p.m., New York City time, on the earlier
to occur of (i) five years following the completion of the Company’s initial business combination with respect to the Public
Warrants, and (ii) the date fixed for redemption of the Public Warrants as provided in Section 6 of this Warrant Agreement with
respect to the Public Warrants (“Expiration Date”). Notwithstanding the foregoing, any Warrants held by
Up and Up Capital, the Representative, or their respective affiliates will not be exercisable more than five years from the effective
date of the Registration Statement in accordance with FINRA Rule 5110(g)(8)(a).  Except with respect to the right to receive
the Redemption Price (as set forth in Section 6 hereunder), each Warrant not exercised on or before the Expiration Date shall
become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement shall cease at the close
of business on the Expiration Date. The Company may extend the duration of the Warrants by delaying the Expiration Date; provided,
however, that the Company will provide written notice of not less than 20 days to Registered Holders of such extension and that
such extension shall be identical in duration among all of the then outstanding Warrants.

 

    	2

     

    

 

3.3
Exercise of Warrants.

 

3.3.1
Cash Exercise. Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by the
Company, may be exercised by the Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office
of its successor as Warrant Agent, currently being:

 

VStock
Transfer, LLC

18
Lafayette Place

Woodmere,
NY 11598

 

with
the subscription form, as set forth in the Warrant, duly executed, and by paying in full, in lawful money of the United States,
by certified or bank cashier’s check payable to the order of the Warrant Agent or by wire transfer to the Warrant Agent’s
bank account, the Warrant Price for each whole Warrant Share as to which the Warrant is exercised and any and all applicable taxes
due in connection with the exercise of the Warrant, the exchange of the Warrant for the Warrant Shares, and the issuance of the
Warrant Shares (such exercise, a “Cash Exercise”). A Cash Exercise in accordance with this Section 3.3.1 is
available to the Registered Holder only during such times that there is an effective registration statement registering the Warrant
Shares, with the prospectus contained therein being available for the resale of the Warrant Shares.

 

3.3.2
Cashless Exercise. Notwithstanding anything contained herein to the contrary, if there is no effective registration statement
registering the Warrant Shares on any day the Registered Holder desires to exercise the Warrants and more than 90 days have passed
since the Company completed its initial business combination, the Registered Holder may exercise the Warrants in whole or in part
in lieu of making a cash payment, by providing notice to the Chief Financial Officer of the Company in a subscription form of
its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Shares determined
as follows:

 

X
= Y [(A-B)/A]

 

where:

 

X
= the number of Warrant Shares to be issued to the Holder.

 

Y
= the number of Warrant Shares with respect to which this Warrant is being exercised.

 

A
= the fair market value of one share of Common Stock.

 

B
= the Warrant Price.

 

The
Registered Holder may not exercise any Public Warrants in the absence of a registration statement except pursuant to this Section
3.3.2. For purposes of this Section 3.3.2 and Section 4.1, the fair market value of one share of Common Stock
is defined as follows:

 

(i)
if the Company’s Common Stock is listed and traded on the New York Stock Exchange, the NYSE American, the NASDAQ Global
Select Market, the NASDAQ Global Market or the NASDAQ Capital Market (each, a “Trading Market”), the fair market
value shall be (A) with respect to the Public Warrants, the average reported last sale price of the shares of Common Stock for
the 10 trading days ending on the third trading day prior to the date the subscription form is submitted to the Company in connection
with the exercise of the Public Warrant, and (B) with respect to the Private Warrants, at the discretion of the holder, either
(x) the average reported last sale price of the shares of Common Stock for the 10 trading days ending on the third trading day
prior to the date the subscription form is submitted to the Company in connection with the exercise of the Private Warrant or
(y) the last reported sale price of the shares of Common Stock for the trading day prior to the date the subscription form is
submitted to the Company in connection with the exercise of the Private Warrant; or

 

    	3

     

    

 

(ii)
if the Company’s Common Stock is not listed on a Trading Market, but is traded in the over-the-counter market, the fair
market value shall be deemed to be the bid price on such Trading Market for the trading day ending immediately prior to the date
the subscription form is submitted in connection with the exercise of the Warrant; or

 

(iii)
if there is no active public market for the Company’s Common Stock, the fair market value of the Common Stock shall be determined
in good faith by the Company’s board of directors.

 

3.3.3 Fractional
Shares. Notwithstanding any provision to the contrary contained in this Warrant Agreement, the Company shall not be
required to issue any fraction of a Warrant Share in connection with the exercise of Warrants, and in any case where the
Registered Holder would be entitled under the terms of the Warrants to receive a fraction of a Warrant Share upon the
exercise of such Registered Holder’s Warrants, issue or cause to be issued only the largest whole number of Warrant
Shares issuable on such exercise (and such fraction of a Warrant Share will be disregarded); provided, that if more than one
Warrant certificate is presented for exercise at the same time by the same Registered Holder, the number of whole Warrant
Shares which shall be issuable upon the exercise thereof shall be computed on the basis of the aggregate number of Warrant
Shares issuable on exercise of all such Warrants.

 

3.3.4
Issuance of Certificates. No later than three (3) business days following the exercise of any Warrant and the clearance
of the funds in payment of the Warrant Price pursuant to Section 3.3.1 or cashless exercise pursuant to Section 3.3.2, the Company
shall issue, or cause to be issued, to the Registered Holder of such Warrant a certificate or certificates representing (or at
the option of the Registered Holder, deliver electronically through the facilities of the Depository Trust Corporation) the number
of full shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him,
her or it, and, if such Warrant shall not have been exercised or surrendered in full, a new countersigned Warrant for the number
of shares as to which such Warrant shall not have been exercised or surrendered. Notwithstanding the foregoing, the Company shall
not deliver, or cause to be delivered, any securities without applicable restrictive legend pursuant to the exercise of a Warrant
unless (a) a registration statement under the Act with respect to the shares of Common Stock issuable upon exercise of such Warrants
is effective and a current prospectus relating to the shares of Common Stock issuable upon exercise of the Warrants is available
for delivery to the Registered Holder of the Warrant or (b) in the opinion of counsel to the Company, the exercise of the Warrants
is exempt from the registration requirements of the Act and such securities are qualified for sale or exempt from qualification
under applicable securities laws of the states or other jurisdictions in which the Registered Holder resides. Warrants may not
be exercised by, or securities issued to, any Registered Holder in any state in which such exercise or issuance would be unlawful.
In addition, in no event will the Company be obligated to pay such Registered Holder any cash consideration upon exercise or otherwise
“net cash settle” the Warrant.

 

3.3.5
Valid Issuance. All shares of Common Stock issued upon the proper exercise or surrender of a Warrant in conformity with
this Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.6
Date of Issuance. Each person or entity in whose name any such certificate for shares of Common Stock is issued shall,
for all purposes, be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered
and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date
of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to
have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are
open.

 

    	4

     

    

 

3.3.7
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the
provisions contained in this subsection 3.3.7; however, no holder of a Warrant shall be subject to this subsection 3.3.7 unless
he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the
holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect
to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would
beneficially own in excess of 9.9% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by such person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrant
with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be
issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates
and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned
by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred shares or warrants)
subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number
of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other
public filing with the SEC as the case may be, (2) a more recent public announcement by the Company, or (3) any other notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time,
upon the written request of the holder of the Warrant, the Company shall, within two (2) business days, confirm orally and in
writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of
Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the
holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported.

 

4.
Adjustments.

 

4.1
Stock Dividends, Splits. If, after the date hereof, and subject to the provisions of Section 4.5 below, the number of outstanding
shares of Common Stock is increased or decreased by a stock dividend payable in shares of Common Stock, or by a forward or reverse
split of shares of Common Stock, or other similar event, then, on the effective date of such stock dividend, split or similar
event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased or decreased in proportion
to such increase or decrease in outstanding shares of Common Stock. A rights offering to all holders of the shares of Common Stock
entitling holders to purchase shares of Common Stock at a price less than the “Historical Fair Market Value” (as defined
below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares
of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering
that are convertible into or exercisable for the shares of Common Stock) multiplied by (ii) one (1) minus the quotient of (x)
the price per share of Common Stock paid in such rights offering divided by (y) the Historical Fair Market Value. For purposes
of this subsection 4.1, (i) if the rights offering is for securities convertible into or exercisable for shares of Common Stock,
in determining the price payable for the shares of Common Stock, there shall be taken into account any consideration received
for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair Market
Value” means the volume weighted average price of the Common Stock as reported during the ten (10) trading day period
ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the
applicable market, regular way, without the right to receive such rights. No shares of Common Stock shall be issued at less than
their par value.

 

4.2
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 4.6, the number of outstanding
shares of Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar
event (other than a change covered by Section 4.1), then, on the effective date of such consolidation, combination, reclassification
or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to
such decrease in outstanding shares of Common Stock.

 

    	5

     

    

 

4.3
Extraordinary Dividends. If the Company, at any time while the Warrants (or rights to purchase the Warrants) are outstanding
and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Common Stock
on account of such Common Stock (or other shares of the Company’s capital stock into which the Warrants are convertible),
other than (a) as described in subsection 4.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the conversion
rights of the holders of the Common Stock in connection with a proposed initial business combination, (d) as a result of the repurchase
of Common Stock by the Company in connection with an initial business combination or as otherwise permitted by the Investment
Management Trust Agreement between the Company and Wilmington Trust, National Association dated of even date herewith or (e) in
connection with the Company’s liquidation and the distribution of its assets upon its failure to consummate a business combination
(any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price
shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the
fair market value (as determined by the Company’s board of directors, in good faith) of any securities or other assets paid
on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.3, “Ordinary
Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis with the per
share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on
the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in
other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant
Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the
offering price of the Units in the Offering).

 

4.4
Adjustments in Exercise Price.

 

4.4.1
Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in Sections
4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price, immediately prior
to such adjustment, by a fraction, (a) the numerator of which shall be the number of shares of Common Stock purchasable upon the
exercise of the Warrants immediately prior to such adjustment, and (b) the denominator of which shall be the number of shares
of Common Stock so purchasable immediately thereafter.

 

4.4.2
If (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection
with the closing of the initial business combination at an issue price or effective issue price of less than $9.50 per share of
Common Stock (with such issue price or effective issue price to be determined in good faith by the Board), (y) the aggregate gross
proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for funding
the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Common Stock during
the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial business combination
(such price, the “Market Value”) is below $9.50 per share, the Warrant Price shall be adjusted (to the nearest
cent) to be equal to 115% of the Market Value, and the last sales price of the Common Stock that triggers the Company’s
right to redeem the Warrants pursuant to Section 6.1 below shall be adjusted (to the nearest cent) to be equal to 165% of the
Market Value.

 

4.5
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
shares of Common Stock (other than a change covered by Sections 4.1 or 4.2 hereof or one that solely affects the par value of
such shares of Common Stock), or, in the case of any merger or consolidation of the Company with or into another corporation (other
than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding shares of Common Stock), or, in the case of any sale or conveyance to another corporation
or entity of the assets or other property of the Company as an entirety or substantially as an entirety, in connection with which
the Company is dissolved, the Registered Holders shall thereafter have the right to purchase and receive, upon the basis and upon
the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other
securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon
a dissolution following any such sale or transfer, that the Registered Holder would have received if such Registered Holder had
exercised his, her or its Warrant(s) immediately prior to such event; and if any reclassification also results in a change in
shares of Common Stock covered by Sections 4.1 or 4.2, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3 and
this Section 4.4. The provisions of this Section 4.5 shall similarly apply to successive reclassifications, reorganizations, mergers
or consolidations, sales or other transfers.

 

    	6

     

    

 

4.6
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting
from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise
of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
Upon the occurrence of any event specified in Sections 4.1 – 4.5 the Company shall give written notice to each Registered
Holder, at the last address set forth for such Registered Holder in the Warrant Register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.7
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants
issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially
issued pursuant to this Warrant Agreement. However, the Company may, at any time, in its sole discretion, make any change in the
form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so
changed.

 

4.8
Notice of Certain Transactions. In the event that the Company shall (a) offer to holders of all its Common Stock rights
to subscribe for or to purchase any securities convertible into shares of Common Stock or shares of stock of any class or any
other securities, rights or options, (b) issue any rights, options or warrants entitling all the holders of Common Stock to subscribe
for shares of Common Stock, or (c) make a tender offer, redemption offer or exchange offer with respect to the Common Stock, the
Company shall send to the Registered Holders a notice of such action or offer. Such notice shall be mailed to the Registered Holders
at their addresses as they appear in the Warrant Register, which shall specify the record date for the purposes of such dividend,
distribution or rights, or the date such issuance or event is to take place and the date of participation therein by the holders
of Common Stock, if any such date is to be fixed, and shall briefly indicate the effect of such action on the Common Stock and
on the number and kind of any other shares of stock and on other property, if any, and the number of shares of Common Stock and
other property, if any, issuable upon exercise of each Warrant and the Warrant Price after giving effect to any adjustment pursuant
to this Section 4 which would be required as a result of such action. Such notice shall be given as promptly as practicable after
the Company has taken any such action.

 

4.9
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i)
avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case,
the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national
standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary
to effectuate the intent and purpose of this Section 4 and, if such firm determines that an adjustment is necessary, the terms
of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended
in such opinion

 

5.
Transfer and Exchange of Warrants.

 

5.1
Transfer of Public Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together
with the Unit in which such Public Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer
or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer
the Public Warrants included in such Unit. From and after the Detachment Date, this Section 5.1 will have no further force and
effect.

 

5.2
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant
into the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed
and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate
number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall
be delivered by the Warrant Agent to the Company from time to time upon the Company’s request.

 

    	7

     

    

 

5.3
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request
for exchange or transfer, and, thereupon, the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested
by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however,
that, in the event a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant
and shall issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating
that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

 

5.4
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will
result in the issuance of a warrant certificate for a fraction of a warrant.

 

5.5
Service Charges. No service charge shall be made to the Warrant Agent for any exchange or registration of transfer of Warrants.

 

5.6
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance
with the terms of this Warrant Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and
the Company, whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the
Company for such purpose.

 

5.7
Private Warrants. The Warrant Agent shall not register any transfer of Private Warrants until after the Warrant Agent shall
be presented with written documentation pursuant to which each transferee or the trustee or legal guardian for such transferee
agrees to be bound by the terms of the Subscription Agreements.

 

6.
Redemption.

 

6.1
Redemption. Subject to the second sentence of this Section 6.1, all (and not less than all) of the outstanding Public Warrants
may be redeemed, in whole and not in part, at the option of the Company, at any time from and after the Public Warrants become
exercisable, and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at
the price of $0.01 per Public Warrant (“Redemption Price”); provided that the last sales price of the Common
Stock has been equal to or greater than $16.50 per share (subject to adjustment for splits, dividends, recapitalizations and other
similar events), for any twenty (20) trading days within a thirty (30) trading day period ending on the third business day prior
to the date on which notice of redemption is given and provided further that there is a current registration statement in effect
with respect to the shares of Common Stock underlying the Public Warrants for each day in the aforementioned 30-day trading period
and continuing each day thereafter until the Redemption Date (defined below). For avoidance of doubt, if and when the Public Warrants
become redeemable by the Company under this Section, the Company may exercise its redemption right, even if it is unable to register
or qualify the Public Warrant Shares for sale under all applicable state securities laws.

 

6.2
Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Public Warrants, the
Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by
first class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption to the Registered
Holders of the Public Warrants to be redeemed at their last addresses as they shall appear on the Warrant Register. Any notice
mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the Registered Holder
received such notice.

 

6.3
Exercise After Notice of Redemption. The Public Warrants may be exercised in accordance with Section 3 of this Warrant
Agreement at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior
to the Redemption Date; provided that the Company may require the Registered Holder who desires to exercise the Public Warrant
to elect cashless exercise as set forth under Section 3.3.2, and such Registered Holder must exercise the Public Warrants on a
cashless basis if the Company so requires. On and after the Redemption Date, the Registered Holder of the Warrants shall have
no further rights except to receive, upon surrender of the Public Warrants, the Redemption Price.

 

    	8

     

    

 

6.4
No Other Rights to Cash Payment. Except for a redemption in accordance with this Section 6, no Registered Holder of any
Public Warrant shall be entitled to any cash payment whatsoever from the Company in connection with the ownership, exercise or
surrender of any Public Warrant under this Warrant Agreement.

 

6.5
Exclusion of Certain Warrants. The Company understands that the redemption rights provided for by this Section 6 apply
only to outstanding Public Warrants. To the extent a person holds rights to purchase Public Warrants, such purchase rights shall
not be extinguished by redemption. However, once such purchase rights are exercised, the Company may redeem the Public Warrants
issued upon such exercise provided that the criteria for redemption is met. Additionally, any of the Private Warrants shall not
be redeemable by the Company. The provisions of this Section 6.5 may not be modified, amended or deleted without the prior written
consent of the Representative.

 

7.
Other Provisions Relating to Rights of Registered
Holders of Warrants.

 

7.1
No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder
of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive
rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of
directors of the Company or any other matter.

 

7.2
Lost, Stolen Mutilated or Destroyed Warrants. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the
Warrant Agent may, on such terms as to indemnity or otherwise as they may in their discretion impose (which terms shall, in the
case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant
so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3
Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this
Warrant Agreement.

 

7.4
Registration of Common Stock. The Company agrees that as soon as practicable, but in no event later than thirty (30) business
days after the closing of a business combination, it shall use its best efforts to file with the SEC a registration statement
for the registration under the Act of the shares of Common Stock issuable upon exercise of the Warrants, and to cause the same
to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto,
until the expiration of the Warrants in accordance with the provisions of this Agreement. In addition, the Company agrees to use
its best efforts to register the shares of Common Stock issuable upon exercise of the Warrants under state blue sky laws, to the
extent an exemption is not available.

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1
Payment of Taxes. The Company will, from time to time, promptly pay all taxes and charges that may be imposed upon the
Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but
the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the
Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall
appoint, in writing, a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment
within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by
the Registered Holder of the Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company),
then the Registered Holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for
the appointment of a successor Warrant Agent. Any successor Warrant Agent, whether appointed by the Company or by such court,
shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal
office in the Borough of Manhattan, City and State of New York, and be authorized under such laws to exercise corporate trust
powers and subject to supervision or examination by federal or state authorities. After appointment, any successor Warrant Agent
shall be vested with all the authority, powers, rights, immunities, duties and obligations of its predecessor Warrant Agent with
like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but, if for any reason it becomes
necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder;
and, upon request of any successor Warrant Agent, the Company shall make, execute, acknowledge, and deliver any and all instruments
in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
rights, immunities, duties and obligations.

 

    	9

     

    

 

8.2.2
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any
such appointment.

 

8.2.3
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may
be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall
be the successor Warrant Agent under this Warrant Agreement without any further act on the part of the Company or the Warrant
Agent.

 

8.3
Fees and Expenses of Warrant Agent.

 

8.3.1
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as Warrant Agent hereunder
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution
of its duties hereunder.

 

8.3.2
Further Assurances. The Company agrees to perform, execute, acknowledge and deliver, or cause to be performed, executed,
acknowledged and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Warrant
Agent for the carrying out or performing of the provisions of this Warrant Agreement.

 

8.4
Liability of Warrant Agent.

 

8.4.1
Reliance on Company Statement. Whenever, in the performance of its duties under this Warrant Agreement, the Warrant Agent
shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering
any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be
deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer
or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for
any action taken or suffered in good faith by it pursuant to the provisions of this Warrant Agreement.

 

8.4.2
Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and hold it harmless against any and all liabilities, including judgments, costs
and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Warrant Agreement, except
as a result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

 

8.4.3
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Warrant Agreement or with
respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any
breach by the Company of any covenant or condition contained in this Warrant Agreement or in any Warrant; nor shall it be responsible
to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method or amount of any
such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it, by any act
hereunder, be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock
to be issued pursuant to this Warrant Agreement or any Warrant or as to whether any shares of Common Stock will when issued be
valid and fully paid and non-assessable.

 

    	10

     

    

 

8.5
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Warrant Agreement and agrees to perform
the same upon the terms and conditions herein set forth and, among other things, shall account promptly to the Company with respect
to Warrants exercised and concurrently account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase
of shares of the Company’s Common Stock through the exercise of Warrants.

 

8.6
Waiver. The Warrant Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in or to any distribution of the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of
the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

9.
Miscellaneous Provisions.

 

9.1
Successors. All the covenants and provisions of this Warrant Agreement by or for the benefit of the Company or the Warrant
Agent shall bind and inure to the benefit of their respective successors and assigns.

 

9.2
Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent
or by the Registered Holder of any Warrant to or on the Company shall be delivered by hand or sent by registered or certified
mail or overnight courier service, addressed (until another address is filed in writing by the Company with the Warrant Agent)
as follows:

 

Globis
Acquisition Corp

805
Third Avenue, 15th floor

New
York, New York 10022

Attn:
Paul Packer

 

with
a copy (which shall not constitute notice) to:

 

Haynes
and Boone, LLP

30
Rockefeller Plaza, 26th Floor

New
York, New York 10112

Attn:
Rick A. Werner

 

Any
notice, statement or demand authorized by this Warrant Agreement to be given or made by the Registered Holder of any Warrant or
by the Company to or on the Warrant Agent shall be delivered by hand or sent by registered or certified mail or overnight courier
service, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

VStock
Transfer, LLC

18
Lafayette Place

Woodmere,
NY 11598

 

Any
notice, sent pursuant to this Warrant Agreement shall be effective, if delivered by hand, upon receipt thereof by the party to
whom it is addressed, if sent by overnight courier, on the next business day of the delivery to the courier, and if sent by registered
or certified mail on the third day after registration or certification thereof.

 

9.3
Applicable Law. The validity, interpretation, and performance of this Warrant Agreement and of the Warrants shall be governed
in all respects by the laws of the State of New York, without giving effect to conflict of laws. The Company and the Warrant Agent
hereby agree that any action, proceeding or claim against either of them arising out of or relating in any way to this Warrant
Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern
District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company and the
Warrant Agent hereby waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
Any such process or summons to be served upon the Company or the Warrant Agent may be served by transmitting a copy thereof by
registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2
hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the party receiving such service in
any action, proceeding or claim.

 

    	11

     

    

 

9.4
Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be
implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation
other than the parties hereto and the Registered Holders of the Warrants and, for the purposes of Sections 9.2 hereof, the Representative
and the underwriters, any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this
Warrant Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the
Registered Holders of the Warrants.

 

9.5
Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the
office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of
any Warrant. The Warrant Agent may require any such Registered Holder to submit his, her or its Warrant for inspection.

 

9.6
Counterparts- Facsimile Signatures. This Warrant Agreement may be executed in any number of counterparts, and each of such
counterparts shall, for all purposes, be deemed to be an original, and all such counterparts shall together constitute one and
the same instrument. Facsimile signatures shall constitute original signatures for all purposes of this Warrant Agreement.

 

9.7
Effect of Headings. The section headings herein are for convenience only and are not part of this Warrant Agreement and
shall not affect the interpretation thereof

 

9.8
Amendments. This Warrant Agreement and any Warrant certificate may be amended by the parties hereto by executing a supplemental
warrant agreement (a “Supplemental Agreement”), without the consent of any of the Warrant Holders, for the
purpose of (i) curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein, or making
any other provisions with respect to matters or questions arising under this Warrant Agreement that is not inconsistent with the
provisions of this Warrant Agreement or the Warrant certificates, (ii) evidencing the succession of another corporation to the
Company and the assumption by any such successor of the covenants of the Company contained in this Warrant Agreement and the Warrants,
(iii) evidencing and providing for the acceptance of appointment by a successor Warrant Agent with respect to the Warrants, (iv)
adding to the covenants of the Company for the benefit of the Registered Holders or surrendering any right or power conferred
upon the Company under this Warrant Agreement, or (viii) amending this Warrant Agreement and the Warrants in any manner that the
Company may deem to be necessary or desirable and that will not adversely affect the interests of the Registered Holders in any
material respect. All other modifications or amendments to this Warrant Agreement, including any amendment to increase the Warrant
Price or shorten the Exercise Period, shall require the written consent of the Registered Holders of a majority of the then outstanding
Warrants. Notwithstanding the foregoing, the Company may extend the duration of the Exercise Period in accordance with Section
3.2 without such consent and an exchange offer made in respect of both the Public Warrants and the Private Warrants on the same
terms will not constitute an amendment requiring consent of any Warrant Holder.

 

9.9
Severability. This Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore,
in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part
of this Warrant Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be
valid and enforceable.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	12

     

    

 

IN
WITNESS WHEREOF, this Warrant Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

 

	 	 GLOBIS
    ACQUISITION CORP.
	 	 	 
	 	By:	 
	 	Name:	Paul
    Packer
	 	Title:	Chief
    Executive Officer and Chief Financial Officer 

 

	 	VSTOCK
    TRANSFER, LLC 
	 	 	
	 		                      
	 	By:	
	 	Name:	
	 	Title:	

 

[SIGNATURE
PAGE TO THE WARRANT AGREEMENT]

 

    	13Exhibit
10.1

 

[Date]

 

Globis
Acquisition Corp.

805
Third Avenue, 15th floor

New
York, New York 10022

 

Re:
Initial Public Offering

 

Ladies
and Gentlemen:

 

This
letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting
Agreement”) entered into by and among Globis Acquisition Corp., a Delaware corporation (the “Company”), and
Chardan Capital Markets LLC, as representative (the “Representative”) of the several underwriters (each, an “Underwriter”
and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”),
of up to 11,500,000 of the Company’s units (including up to 1,500,000 units that may be purchased to cover over-allotments,
if any) (the “Units”), each comprised of one share of the Company’s common stock, par value $0.0001 per share
(the “Common Stock”), and one redeemable warrant to purchase one share of Common Stock (each, a “Warrant”).
Each Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment
as described in the Prospectus (as defined below). The Units will be sold in the Public Offering pursuant to a registration statement
on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange Commission
(the “Commission”) and the Company has applied to have the Units listed on The Nasdaq Capital Market. Certain capitalized
terms used herein are defined in paragraph 10 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of Globis SPAC
LLC and Up and Up Capital, LLC (each, a “Sponsor” and together, the “Sponsors”), the undersigned individuals,
each of whom is a member of the Company’s board of directors and/or management team or a designee of Globis SPAC LLC (each
of the undersigned individuals, an “Insider” and collectively, the “Insiders”) and the Representative
(solely with respect to the Equity Participation Shares), hereby agrees with the Company as follows:

 

		1.	The
                                         Representative, each Sponsor and each Insider agrees that if the Company seeks stockholder
                                         approval of a proposed Business Combination, then in connection with such proposed Business
                                         Combination, it, he or she shall (i) vote any shares of Common Stock owned or controlled
                                         directly or indirectly by it, him or her in favor of any proposed Business Combination
                                         and (ii) not redeem any shares of Common Stock owned by it, him or her in connection
                                         with such stockholder approval. If the Company seeks to consummate a proposed Business
                                         Combination by engaging in a tender offer, the Representative, each Sponsor and each
                                         Insider agrees that it, he or she will not sell or tender any shares of Common Stock
                                         owned by it, him or her in connection therewith.

 

    	 

     

    

 

		2.	Each
                                         Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate
                                         a Business Combination within 12 months (or up to 18 months from the closing of the Public
                                         Offering if the Company extends the period of time to consummate a Business Combination,
                                         as described in more detail in the Prospectus) from the closing of the Public Offering,
                                         or such later period approved by the Company’s stockholders in accordance with
                                         the Company’s amended and restated certificate of incorporation (as it may be amended
                                         from time to time, the “Charter”), each Sponsor and each Insider shall take
                                         all reasonable steps to cause the Company to (i) cease all operations except for the
                                         purpose of winding up, (ii) as promptly as reasonably possible but not more than ten
                                         business days thereafter, redeem 100% of the shares of Common Stock sold as part of the
                                         Units in the Public Offering (the “Offering Shares”), at a per-share price,
                                         payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as
                                         defined below), including interest earned on the funds held in the Trust Account (excluding
                                         up to $100,000 of interest to pay dissolution expenses) and not previously released to
                                         the Company to pay the Company’s income tax or other tax obligations, divided by
                                         the number of then outstanding Offering Shares, which redemption will completely extinguish
                                         all Public Stockholders’ (as defined below) rights as stockholders (including the
                                         right to receive further liquidating distributions, if any), and (iii) as promptly as
                                         reasonably possible following such redemption, subject to the approval of the Company’s
                                         remaining stockholders and the Company’s board of directors, liquidate and dissolve,
                                         subject in each case to the Company’s obligations under Delaware law to provide
                                         for claims of creditors and other requirements of applicable law. Each Sponsor and each
                                         Insider agrees to not propose any amendment to the Charter to modify the substance or
                                         timing of the Company’s obligation to redeem 100% of the Offering Shares if the
                                         Company does not complete a Business Combination within the required time period set
                                         forth in the Charter or with respect to any other material provisions relating to stockholders’
                                         rights or pre-initial business combination activity, unless the Company provides its
                                         Public Stockholders with the opportunity to redeem their Offering Shares upon approval
                                         of any such amendment at a per-share price, payable in cash, equal to the aggregate amount
                                         then on deposit in the Trust Account, including interest earned on the funds held in
                                         the Trust Account and not previously released to the Company to pay the Company’s
                                         income tax or other tax obligations, divided by the number of then outstanding Offering
                                         Shares.
	 	 	 
	 	 	Each
                                         Sponsor and each Insider acknowledges that it, he or she has no right, title, interest
                                         or claim of any kind in or to any monies held in the Trust Account or any other asset
                                         of the Company as a result of any liquidation of the Company with respect to the Founder
                                         Shares held by it, him or her. The Representative, each Sponsor and each Insider hereby
                                         further waives, with respect to any shares of Common Stock held by it, him or her, if
                                         any, any redemption rights it, he or she may have in connection with (A) the consummation
                                         of a Business Combination, including, without limitation, any such rights available in
                                         the context of a stockholder vote to approve such Business Combination, or (B) a stockholder
                                         vote to approve an amendment to the Charter to modify the substance or timing of the
                                         Company’s obligation to redeem 100% of the Offering Shares if the Company has not
                                         consummated a Business Combination within the time period set forth in the Charter or
                                         with respect to any other material provisions relating to stockholders’ rights
                                         or pre-initial business combination activity or in the context of a tender offer made
                                         by the Company to purchase Offering Shares (although the Representative, the Sponsors,
                                         the Insiders and their respective affiliates shall be entitled to redemption and liquidation
                                         rights with respect to any Offering Shares it or they hold if the Company fails to consummate
                                         a Business Combination within the time period set forth in the Charter).

 

    	 

     

    

 

		3.	In
                                         the event of the liquidation of the Trust Account upon the failure of the Company to
                                         consummate its initial Business Combination within the time period set forth in the Charter,
                                         the Sponsors (the “Indemnitors”) agree to indemnify and hold harmless the
                                         Company against any and all loss, liability, claim, damage and expense whatsoever (including,
                                         but not limited to, any and all legal or other expenses reasonably incurred in investigating,
                                         preparing or defending against any litigation, whether pending or threatened) to which
                                         the Company may become subject as a result of any claim by (i) any third party for services
                                         rendered or products sold to the Company or (ii) any prospective target business with
                                         which the Company has entered into a written letter of intent, confidentiality or other
                                         similar agreement or Business Combination agreement (a “Target”); provided,
                                         however, that such indemnification of the Company by the Indemnitors (x) shall apply
                                         only to the extent necessary to ensure that such claims by a third party or a Target
                                         do not reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00
                                         per Offering Share and (ii) the actual amount per Offering Share held in the Trust Account
                                         as of the date of the liquidation of the Trust Account, if less than $10.00 per Offering
                                         Share, is then held in the Trust Account due to reductions in the value of the trust
                                         assets, less taxes payable, (y) shall not apply to any claims by a third party or a Target
                                         which executed a waiver of any and all rights to the monies held in the Trust Account
                                         (whether or not such waiver is enforceable) and (z) shall not apply to any claims under
                                         the Company’s indemnity of the Underwriters against certain liabilities, including
                                         liabilities under the Securities Act of 1933, as amended. The Indemnitors shall have
                                         the right to defend against any such claim with counsel of their choice reasonably satisfactory
                                         to the Company if, within 15 days following written receipt of notice of the claim to
                                         the Indemnitors, the Indemnitors notify the Company in writing that they shall undertake
                                         such defense.

 

		4.	Each
                                         Sponsor, each Insider and the Representative hereby agrees and acknowledges that: (i)
                                         the Underwriters and the Company would be irreparably injured in the event of a breach
                                         by such Sponsors or an Insider of its, his or her obligations under paragraphs 1, 2,
                                         3 and 5(b), as applicable, of this Letter Agreement, (ii) monetary damages may not be
                                         an adequate remedy for such breach and (iii) the non-breaching party shall be entitled
                                         to seek injunctive relief, in addition to any other remedy that such party may have in
                                         law or in equity, in the event of such breach.

 

		5.	(a)
                                         Each Sponsor and each Insider agrees that it shall not Transfer (defined below) any Sponsor/Insider
                                         Securities (defined below) until the completion of a Business Combination (the “Lock-up
                                         Period”).
	 	 	 
	 	 	(b)
                                         Notwithstanding the provisions set forth in paragraphs 5(a), Transfers of any Sponsor/Insider
                                         Securities that are held by each Sponsor, any Insider or any of their permitted transferees
                                         (that have complied with this paragraph 5(b)), are permitted (i) to the Company or its
                                         officers or directors, any affiliate or family member of any of the Company’s officers
                                         or directors, any affiliate of the Sponsors or to any members of the Sponsors or any
                                         of their affiliates or family members; (ii) in the case of an individual, by gift to
                                         a member of such individual’s immediate family or to a trust, the beneficiary of
                                         which is a member of such individual’s immediate family, an affiliate of such individual;
                                         (iii) in the case of an individual, by virtue of laws of descent and distribution upon
                                         death of such individual; (iv) in the case of an individual, pursuant to a qualified
                                         domestic relations order; (v) by private sales or transfers made in connection with any
                                         forward purchase agreement or similar arrangement or in connection with the consummation
                                         of an initial Business Combination at prices no greater than the price at which the securities
                                         were originally purchased; (vi) in the event of the Company’s liquidation prior
                                         to the completion of an initial Business Combination; (vii) by virtue of the laws of
                                         the State of Delaware or the either Sponsor’s limited liability company agreement
                                         upon dissolution of such Sponsor; or (viii) in the event of the Company’s liquidation,
                                         merger, capital stock exchange or other similar transaction which results in all of the
                                         Company’s stockholders having the right to exchange their shares of Common Stock
                                         for cash, securities or other property subsequent to the Company’s completion of
                                         an initial Business Combination; provided, however, that in the case of clauses (i) through
                                         (v) or (vii), these permitted transferees must enter into a written agreement with the
                                         Company agreeing to be bound by the transfer restrictions herein and the other restrictions
                                         contained in this Letter Agreement (including provisions relating to voting, the Trust
                                         Account and liquidating distributions).

 

    	 

     

    

 

		6.	Each
                                         Insider agrees to offer all suitable business combination opportunities to the Company
                                         before any other person or entity until the consummation of the initial Business Combination,
                                         subject to any pre-existing contractual or fiduciary obligations such Insider may have;
                                         provided, that each Insider shall not be limited with respect to his or her individual
                                         activity as a sponsor or independent director of a separate special purpose acquisition
                                         vehicle that does not conflict or compete with the Company.

 

		7.	Each
                                         Sponsor and each Insider represents and warrants that it, he or she has never been suspended
                                         or expelled from membership in any securities or commodities exchange or association
                                         or had a securities or commodities license or registration denied, suspended or revoked.
                                         Each Insider’s biographical information furnished to the Company (including any
                                         such information included in the Prospectus) is true and accurate in all respects and
                                         does not omit any material information with respect to the Insider’s background.
                                         Each Sponsor and each Insider’s questionnaire furnished to the Company is true
                                         and accurate in all respects. Each Sponsor and each Insider represents and warrants that:
                                         it, he or she is not subject to or a respondent in any legal action for, any injunction,
                                         cease-and-desist order or order or stipulation to desist or refrain from any act or practice
                                         relating to the offering of securities in any jurisdiction; it, he or she has never been
                                         convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any
                                         financial transaction or handling of funds of another person, or (iii) pertaining to
                                         any dealings in any securities and it, he or she is not currently a defendant in any
                                         such criminal proceeding.

 

		8.	Except
                                         as disclosed in the Prospectus, neither the Sponsors nor any officer, nor any affiliate
                                         of the Sponsors or any officer, nor any director of the Company, shall receive from the
                                         Company any finder’s fee, reimbursement, consulting fee, non-cash payments, monies
                                         in respect of any repayment of a loan or other compensation prior to, or in connection
                                         with any services rendered in order to effectuate, the consummation of the Company’s
                                         initial Business Combination (regardless of the type of transaction that it is), other
                                         than the following, none of which will be made from the proceeds held in the Trust Account
                                         prior to the completion of the initial Business Combination: payments to an affiliate
                                         of one of the Sponsors for certain administrative services as may be reasonably required
                                         by the Company of $10,000 per month; reimbursement for any reasonable out-of-pocket expenses
                                         related to identifying, investigating, negotiating and completing an initial Business
                                         Combination, and repayment of loans, if any, and on such terms as to be determined by
                                         the Company from time to time, made by the Sponsors or affiliates of the Sponsors or
                                         any of the Company’s officers or directors to finance transaction costs in connection
                                         with an intended initial Business Combination, provided, that, if the Company does not
                                         consummate an initial Business Combination, a portion of the working capital held outside
                                         the Trust Account may be used by the Company to repay such loaned amounts so long as
                                         no proceeds from the Trust Account are used for such repayment. Such loans may be convertible
                                         into warrants at a price of $0.75 per warrant at the option of the lender. Such warrants
                                         would be identical to the Private Placement Warrants purchased by Globis SPAC LLC, including
                                         as to exercise price, exercisability and exercise period.

 

    	 

     

    

 

		9.	The
                                         Representative, each Sponsor and each Insider has full right and power, without violating
                                         any agreement to which it is bound (including, without limitation, any non-competition
                                         or non-solicitation agreement with any employer or former employer), to enter into this
                                         Letter Agreement and, as applicable, to serve as an officer and/or director on the board
                                         of directors of the Company and hereby consents to being named in the Prospectus as an
                                         officer and/or director of the Company.

 

		10.	As
                                         used herein, (i) “Business Combination” shall mean a merger, capital stock
                                         exchange, asset acquisition, stock purchase, reorganization or similar business combination,
                                         involving the Company and one or more businesses; (ii) “Equity Participation Shares”
                                         shall mean 350,000 shares of Common Stock (or 402,500 shares if the Underwriters’
                                         over-allotment option is exercised in full) to be issued to the Representative as compensation
                                         upon closing of the Public Offering; (iii) “Founder Shares” shall mean the
                                         3,047,500 shares of Common Stock issued and outstanding (up to 397,500 shares of which
                                         are subject to complete or partial forfeiture if the over-allotment option is not exercised
                                         by the Underwriters); (iv) “Private Placement Warrants” shall mean the 4,055,556
                                         warrants (or 4,188,889 warrants if the over-allotment option is exercised in full), each
                                         warrant one warrant to purchase one share of Common Stock that the Sponsors and/or certain
                                         designees of Globis SPAC LLC have agreed to purchase for an aggregate purchase price
                                         of $3,041,667 (or $3,141,667 if the over-allotment option is exercised in full) in a
                                         private placement that shall occur simultaneously with the consummation of the Public
                                         Offering; (v) “Private Placement Units” shall mean the 95,833 Units (or 100,833
                                         Units if the over-allotment option is exercised in full), each comprised of one share
                                         of Common Stock and one warrant to purchase one share of Common Stock, that Up and Up
                                         Capital, LLC has agreed to purchase for an aggregate purchase price of $958,333 (or $1,008,333
                                         if the over-allotment option is exercised in full) in a private placement that shall
                                         occur simultaneously with the consummation of the Public Offering; (vi) “Sponsor/Insider
                                         Securities” shall mean (a) the Private Placement Units, (b) the shares of Common
                                         Stock or Warrants underlying the Private Placement Units, (c) the shares of Common Stock
                                         issued or issuable upon the exercise of Warrants underlying the Private Placement Units,
                                         (d) the Private Placement Warrants, (e) the shares of Common Stock issued or issuable
                                         upon the exercise of the Private Placement Warrants and (f) the Founder Shares; (vii)
                                         “Public Stockholders” shall mean the holders of securities issued in the
                                         Public Offering; (viii) “Trust Account” shall mean the trust fund into which
                                         a portion of the net proceeds of the Public Offering and the sale of the Private Placement
                                         Warrants and Private Placement Units shall be deposited; and (ix) “Transfer”
                                         shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate,
                                         pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose
                                         of, directly or indirectly, or establishment or increase of a put equivalent position
                                         or liquidation with respect to or decrease of a call equivalent position within the meaning
                                         of Section 16 of the Exchange Act, and the rules and regulations of the Commission promulgated
                                         thereunder with respect to, any security, (b) entry into any swap or other arrangement
                                         that transfers to another, in whole or in part, any of the economic consequences of ownership
                                         of any security, whether any such transaction is to be settled by delivery of such securities,
                                         in cash or otherwise, or (c) public announcement of any intention to effect any transaction
                                         specified in clause (a) or (b).

 

    	 

     

    

 

		11.	The
                                         Company will maintain an insurance policy or policies providing directors’ and
                                         officers’ liability insurance, and each Director shall be covered by such policy
                                         or policies, in accordance with its or their terms, to the maximum extent of the coverage
                                         available for any of the Company’s directors or officers.

 

		12.	This
                                         Letter Agreement constitutes the entire agreement and understanding of the parties hereto
                                         in respect of the subject matter hereof and supersedes all prior understandings, agreements,
                                         or representations by or among the parties hereto, written or oral, to the extent they
                                         relate in any way to the subject matter hereof or the transactions contemplated hereby.
                                         This Letter Agreement may not be changed, amended, modified or waived (other than to
                                         correct a typographical error) as to any particular provision, except by a written instrument
                                         executed by all parties hereto.

 

		13.	No
                                         party hereto may assign either this Letter Agreement or any of its rights, interests,
                                         or obligations hereunder without the prior written consent of the other parties. Any
                                         purported assignment in violation of this paragraph shall be void and ineffectual and
                                         shall not operate to transfer or assign any interest or title to the purported assignee.
                                         This Letter Agreement shall be binding on each Sponsor and each Insider and their respective
                                         successors, heirs and assigns and permitted transferees.

 

		14.	Nothing
                                         in this Letter Agreement shall be construed to confer upon, or give to, any person or
                                         corporation other than the parties hereto any right, remedy or claim under or by reason
                                         of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement
                                         hereof. All covenants, conditions, stipulations, promises and agreements contained in
                                         this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto
                                         and their successors, heirs, personal representatives and assigns and permitted transferees.

 

		15.	This
                                         Letter Agreement may be executed in any number of original or facsimile counterparts
                                         and each of such counterparts shall for all purposes be deemed to be an original, and
                                         all such counterparts shall together constitute but one and the same instrument.

 

		16.	This
                                         Letter Agreement shall be deemed severable, and the invalidity or unenforceability of
                                         any term or provision hereof shall not affect the validity or enforceability of this
                                         Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any
                                         such invalid or unenforceable term or provision, the parties hereto intend that there
                                         shall be added as a part of this Letter Agreement a provision as similar in terms to
                                         such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

    	 

     

    

 

		17.	This
                                         Letter Agreement shall be governed by and construed and enforced in accordance with the
                                         laws of the State of New York. The parties hereto (i) all agree that any action, proceeding,
                                         claim or dispute arising out of, or relating in any way to, this Letter Agreement shall
                                         be brought and enforced in the courts of New York City, in the State of New York, and
                                         irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall
                                         be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or
                                         that such courts represent an inconvenient forum.

 

		18.	Any
                                         notice, consent or request to be given in connection with any of the terms or provisions
                                         of this Letter Agreement shall be in writing and shall be sent by express mail or similar
                                         private courier service, by certified mail (return receipt requested), by hand delivery
                                         or facsimile transmission.

 

		19.	This
                                         Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up
                                         Period or (ii) the liquidation of the Company; provided, however, that this Letter Agreement
                                         shall earlier terminate in the event that the Public Offering is not consummated and
                                         closed by December 31, 2021; provided further that paragraph 3 of this Letter Agreement
                                         shall survive such liquidation.

 

[Signature
Page Follows]

 

    	 

     

    

 

	 	Sincerely,
	 	 
	 	Globis
    SPAC LLC
	 	 
	 	By:	 
	 	Name:	Paul
    Packer
	 	Title:	Manager
	 	 
	 	Up
    and Up Capital, LLC
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 
	 	 
	 	Paul
    Packer
	 	 
	 	 
	 	Claude
    Benitah
	 	 
	 	 
	 	Michael
    A. Ferguson
	 	 
	 	
	 	John
    M. Horne
	 	 	 
	 	Chardan
    Capital Markets, LLC
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

  

	Acknowledged
    and Agreed:	 
	 	 
	Globis
    acquisition corp.	 
	 	 
	By:	 

	 
	Name:	Paul
    Packer	 
	Title:	Chief
    Executive Officer, Chief Financial Officer and Secretary	 

 

 

[Signature
Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]